Bicycle Therapeutics Plc ADR (BCYC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
Sales | 19,530 | 5,331 | 5,352 | 11,397 | 4,896 |
Gross Profit | 19,530 | 5,331 | 5,352 | 11,397 | 4,896 |
Operating Expenses | 51,246 | 59,566 | 56,149 | 54,508 | 46,699 |
Operating Income | -31,716 | -54,235 | -50,797 | -43,111 | -41,803 |
Interest Expense | 821 | 820 | 814 | 821 | 808 |
Other Income | 5,624 | 6,276 | 3,985 | 812 | 2,929 |
Pre-tax Income | -26,913 | -48,779 | -47,626 | -43,120 | -39,682 |
Income Tax | -350 | 320 | 2,272 | -517 | -618 |
Net Income Continuous | -26,563 | -49,099 | -49,898 | -42,603 | -39,064 |
Net Income | $-26,563 | $-49,099 | $-49,898 | $-42,603 | $-39,064 |
EPS Basic Total Ops | -0.62 | -1.11 | -1.26 | -1.41 | -1.30 |
EPS Basic Continuous Ops | -0.62 | -1.10 | -1.26 | -1.41 | -1.30 |
EPS Diluted Total Ops | -0.62 | -1.11 | -1.26 | -1.41 | -1.30 |
EPS Diluted Continuous Ops | -0.62 | -1.10 | -1.26 | -1.41 | -1.30 |
EPS Diluted Before Non-Recurring Items | -0.62 | -1.16 | -1.26 | -1.41 | -1.30 |
EBITDA(a) | $-30,058 | $-52,581 | $-49,107 | $-41,466 | $-40,246 |